CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 94  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0658
LYS 10.0102
GLU 20.0075
LEU 30.0131
ARG 40.0162
CYS 50.0198
GLN 60.0062
CYS 70.0086
ILE 80.0049
LYS 90.0109
THR 100.0140
TYR 110.0107
SER 120.0268
LYS 130.0658
PRO 140.0327
PHE 150.0118
HIS 160.0037
PRO 170.0057
LYS 180.0174
PHE 190.0058
ILE 200.0074
LYS 210.0073
GLU 220.0089
LEU 230.0116
ARG 240.0185
VAL 250.0225
ILE 260.0217
GLU 270.0182
SER 280.0191
GLY 290.0274
PRO 300.0275
HIS 310.0222
CYS 320.0091
ALA 330.0108
ASN 340.0115
THR 350.0156
GLU 360.0154
ILE 370.0154
ILE 380.0108
VAL 390.0064
LYS 400.0090
LEU 410.0078
SER 420.0089
ASP 430.0247
GLY 440.0097
ARG 450.0132
GLU 460.0134
LEU 470.0106
CYS 480.0061
LEU 490.0029
ASP 500.0175
PRO 510.0259
LYS 520.0232
GLU 530.0240
ASN 540.0186
TRP 550.0080
VAL 560.0024
GLN 570.0165
ARG 580.0284
VAL 590.0178
VAL 600.0163
GLU 610.0195
LYS 620.0080
PHE 630.0073
LEU 640.0017
LYS 650.0387
ARG 660.0124
ALA 670.0220
GLU 680.0329
ASN 690.0460

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.